Effect of Lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet

Journal of Microbiology and Biotechnology

Volumn 25, Issue 5, 2015, Pages 687-695

  Chen, Dawei ^a   Yang, Zhenquan ^a   Chen, Xia ^a   Huang, Yujun ^a   Yin, Boxing ^a   Guo, Feixiang ^a   Zhao, Haiqing ^a   Huang, Jiadi ^b   Wu, Yun ^b   Gu, Ruixia ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Royal Dairy (Guangxi) Co Ltd   (China)

Author keywords

Gut microbiota; Hypolipidemic; Lactobacillus rhamnosus hsryfm 1301; Real time PCR

Indexed keywords

BILE ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; BIFIDOBACTERIUM; CHOLESTEROL BLOOD LEVEL; CLOSTRIDIUM; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTEROBACTER; ENTEROCOCCUS; FATTY LIVER; FECES ANALYSIS; FERMENTED MILK; FERMENTED PRODUCT; HISTOPATHOLOGY; HYPERLIPIDEMIA; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WATER CONTENT; ANIMAL; CHEMISTRY; DRUG EFFECTS; FECES; FERMENTED MILK PRODUCT; LIVER; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; WISTAR RAT;

BACTEROIDES SP.; BIFIDOBACTERIUM; CLOSTRIDIUM LEPTUM; ENTEROBACTER; ENTEROCOCCUS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; RATTUS;

ANIMALS; CULTURED MILK PRODUCTS; DIET, HIGH-FAT; FECES; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS RHAMNOSUS; LIPID METABOLISM; LIVER; MALE; PROBIOTICS; RATS; RATS, WISTAR;

EID: 84930005411     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1409.09085     Document Type: Article

References (38)

1. An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, et al. 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10: 116.
2. Armstrong MJ, Carey MC. 1982. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reversephase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J. Lipid Res. 23: 70-80.
3. Audisio MC, Oliver G, Apella MC. 2001. Effect of different complex carbon sources on growth and bacteriocin synthesis of Enterococcus faecium. Int. J. Food Microbiol. 63: 235-241.
4. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. 2004. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70: 3575-3581.
5. Begley M, Gahan CG, Hill C. 2005. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29: 625-651.
6. Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. 2005. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl. Environ. Microbiol. 71: 4679-4689.
7. Bry L, Falk PG, Midtvedt T, Gordon JI. 1996. A model of host-microbial interactions in an open mammalian ecosystem. Science 273: 1380-1383.
8. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. 2007. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
9. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
10. Fava F, Lovegrove J, Gitau R, Jackson K, Tuohy K. 2006. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr. Med. Chem. 13: 3005-3021.
11. Fernandez M, Boris S, Barbes C. 2003. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol. 94: 449-455.
12. Fite A, Macfarlane G, Cummings J, Hopkins M, Kong S, Furrie E, Macfarlane S. 2004. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53: 523-529.
13. Gómez-Hurtado I, Santacruz A, Peiró G, Zapater P, Gutiérrez A, Pérez-Mateo M, et al. 2011. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One 6: e23037.
14. Hayashi H, Sakamoto M, Benno Y. 2002. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture - based methods. Microbiol. Immunol. 46: 535-548.
15. Jones ML, Martoni CJ, Parent M, Prakash S. 2012. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br. J. Nutr. 107: 1505-1513.
16. Jones SE, Versalovic J. 2009. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 9: 35.
17. Juang I, Pan T, Huong H, Huang C. 2000. The effect of oligosaccharide beverage on microflora in rats. Chin. J. Nutr. 25: 232-242.
18. Kajiura K, Ohkusa T, Okayasu I. 1998. Relationship between fecal bile acids and the occurrence of colorectal neoplasia in experimental murine ulcerative colitis. Digestion 59: 69-72.
19. Kim K-A, Gu W, Lee I-A, Joh E-H, Kim D-H. 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7: e47713.
20. Kim M, Shin HK. 1998. The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal shortchain fatty acid concentrations and fecal lipid excretion in rats. J. Nutr. 128: 1731-1736.
21. Larkin TA, Astheimer LB, Price WE. 2007. Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 63: 238-245.
22. Macfarlane G, Hay S, Macfarlane S, Gibson G. 1990. Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J. Appl. Bacteriol. 68: 179-187.
23. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100: 373-382.
24. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70: 7220-7228.
25. Meki A-RM, Abdel-Ghaffar SK, El-Gibaly I. 2001. Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin. Neuroendocrinol. Lett. 22: 417-426.
26. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, et al. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Trans. Med. 3: 106ra106- 106ra106.
27. Núñez IN, Galdeano CM, Carmuega E, Weill R, de Moreno de Le Blanc A, Perdigón G. 2013. Effect of a probiotic fermented milk on the thymus in Balb/c mice under nonsevere protein–energy malnutrition. Br. J. Nutr. 110: 500-508.
28. Ohtani O. 1992. The maceration technique in scanning electron microscopy of collagen fiber frameworks: its application in the study of human livers. Arch. Histol. Cytol. 55: 225-225.
29. Pridmore RD, Berger B, Desiere F, Vilanova D, Barretto C, Pittet A-C, et al. 2004. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii N C C 533. Proc. Natl. Acad. Sci. USA 101: 2512-2517.
30. Pryde SE, Duncan SH, Hold GL, S tewart CS, Flint HJ. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217: 133-139.
31. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
32. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1131.
33. Tappenden KA, Deutsch AS. 2007. The physiological relevance of the intestinal microbiota-contributions to human health. J. Am. College Nutr. 26: 679S-683S.
34. Tannock GW. 1998. Studies of the intestinal microflora: a prerequisite for the development of probiotics. Int. Dairy J. 8: 527-533.
35. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Trans. Med. 1: 6ra14-16ra14.
36. WHO: Cardiovascular Disease. In Fact sheet N°317. Geneva, Switzerland; 2009 [http://www.who.int/mediacentre/factsheets/fs317/en/], (accessed on 19 May 2010).
37. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, et al. 2003. A genomic view of the human- Bacteroides thetaiotaomicron symbiosis. Science 299: 2074-2076.
38. Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G. 2010. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16: 3394.